Rising diabetes and obesity prevalence, strong clinical outcomes, patient awareness, insurance coverage, and demand for effective, convenient metabolic therapies drive growth
GLP-1 medications, by comparison, cost $800$1,200 per month, adding up to $10,000+ yearly, making surgery more cost-effective long-term
Algunas opiniones indican que quienes buscan resultados especficos deben tener expectativas realistas respecto a su eficacia individualizada
Role of thyroid dysimmunity and thyroid hormones in endometriosis
Health Secretary Robert F Kennedy has described himself as a "big fan" of the drugs and has previously vowed to ease restrictions on them after the Biden administration clamped down on the growing industry